NEW YORK (GenomeWeb News) – Foundation Medicine has completed a $42.5 million Series B round of financing, the Cambridge, Mass.-based firm announced today.

Investors in the round included Deerfield Management, Casdin Capital, Redmile Group, Roche Venture Fund, and WuXi Corporate Venture Fund, along with founding investor Third Rock Ventures and current venture capital backers Google Ventures and Kleiner Perkins Caufield & Byers. An undisclosed fund and an undisclosed strategic investor also participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.